share_log

5 Value Stocks To Watch In The Healthcare Sector

5 Value Stocks To Watch In The Healthcare Sector

医疗保健领域值得关注的5只价值股
Benzinga Real-time News ·  2022/12/12 09:44

What are Value Stocks?

什么是价值股?

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

传统上,与同行业公司的股票价格相比,价值股票的价格较低。这表明该公司的估值可能被低估了,因为投资者对此类公司的兴趣不大。最常用的价值检查方法是市盈倍数或市盈率。低市盈倍数很好地表明股票被低估了。

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

Benzinga Insights编制了一份可能值得关注的医疗保健行业价值股清单:

  1. Vicarious Surgical (NYSE:RBOT) - P/E: 6.22
  2. Walgreens Boots Alliance (NASDAQ:WBA) - P/E: 8.07
  3. Pfizer (NYSE:PFE) - P/E: 9.91
  4. Aadi Bioscience (NASDAQ:AADI) - P/E: 2.79
  5. Innoviva (NASDAQ:INVA) - P/E: 4.04
  1. 替代外科 (纽约证券交易所代码:RBOT)-市盈率:6.22
  2. 沃尔格林靴子联盟 (纳斯达克股票代码:WBA)-市盈率:8.07
  3. 辉瑞公司 (纽约证券交易所代码:PFE)-市盈率:9.91
  4. 阿迪生物科学 (纳斯达克股票代码:AADI)-市盈率:2.79
  5. Innoviva (纳斯达克股票代码:INVA)-市盈率:4.04

Vicarious Surgical's earnings per share for Q3 sits at $-0.18, whereas in Q2, they were at -0.16. Most recently, Walgreens Boots Alliance reported earnings per share at $0.8, whereas in Q3 earnings per share sat at $0.96. Its most recent dividend yield is at 5.41%, which has increased by 0.35% from 5.06% in the previous quarter.

Vicarious Surgical第三季度的每股收益为-0.18美元,而在第二季度,每股收益为-0.16美元。最近,Walgreens Boots Alliance公布的每股收益为0.8美元,而第三季度每股收益为0.96美元。其最新的股息收益率为5.41%,较上一季度的5.06%增长了0.35%。

Pfizer has reported Q3 earnings per share at $1.78, which has decreased by 12.75% compared to Q2, which was 2.04. Most recently, the company reported a dividend yield of 3.17%, which has decreased by 0.47% from last quarter's yield of 3.64%.

辉瑞公布的第三季度每股收益为1.78美元,与第二季度的2.04美元相比下降了12.75%。最近,该公司公布的股息收益率为3.17%,较上个季度的3.64%下降了0.47%。

Aadi Bioscience saw an increase in earnings per share from -0.69 in Q2 to $-0.68 now. Most recently, Innoviva reported earnings per share at $2.8, whereas in Q2 earnings per share sat at $0.05.

Aadi Bioscience的每股收益从第二季度的-0.69美元增加到现在的-0.68美元。最近,Innoviva公布的每股收益为2.8美元,而第二季度每股收益为0.05美元。

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

这5只价值股票是由以下人士选出的 奔辛加洞察 基于量化分析。虽然这种有条不紊的判断过程并不旨在做出最终决定,但我们的技术可以让投资者对该行业有更多的看法。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发